Abciximab
7 Topics Found
Drug Index
Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.[3] While abciximab has a short plasma half-life, due to its stron...
Abciximab
Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.[3] While abciximab has a short plasma half-life, due to its stron...
Blood Thinner ## I am not sure if this helps but you might find information on ReoPro® (chemical name Abciximab) useful; This drug acts as a platelet aggregation inhibitor (blood thinning agent) during surgical procedures. ## Yes, ReoPro® is a monoclonal antibody directed against platelet receptors. Is Monoclore an actual trade or chemical name for another drug? If so, which country?
2 REPLIES
Filed under
ReoPro
Drug Index
In medicine, glycoprotein IIb/IIIa inhibitors, also GpIIb/IIIa inhibitors, is a class of antiplatelet agents. Several GpIIb/IIIa inhibitors exist: abciximab (abcixifiban) (ReoPro) eptifibatide (Integrilin) tirofiban (Aggrastat) roxifiban orbofiban Use Glycoprotein IIb/IIIa inhibitors are frequently used during percutaneous coronary intervention (angioplasty with or without intracoronary stent placement). They work by preventing platelet aggregation and thrombus formation. They do so b...
ReoPro(Abciximab) is a monoclonal antibody that blocks the pathway to platelet aggregation and reduces cardiac ischemic complications in patients undergoing PCI (percutaneous coronary intervention).
Filed under ReoPro
NDC Database
Reopro 2 mg/ml Intravenous Injection, Solution by Eli Lilly and Company ## Package Codes: 0002-7140-01 ## Active Ingredients: Abciximab
NDC Database
Reopro 2 mg/ml Intravenous Injection, Solution by Janssen Biotech, Inc. ## Package Codes: 57894-200-01 ## Active Ingredients: Abciximab